ClinicalTrialsFinder

RET-altered Non Small Cell Lung Cancer Clinical Trials in Hirakata-shi, Osaka

1 recruitingHirakata-shi, Osaka, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities

RET-altered Non Small Cell Lung CancerRET-altered Solid Tumors
Taiho Pharmaceutical Co., Ltd.244 enrolled21 locationsNCT04683250